eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...

GLP-1 peptide therapeutics are rapidly reshaping the treatment landscape for diabetes and obesity, creating increased demand for robust formulation development and comprehensive analytical ...

U.S. Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Formulation Development Outsourcing Market Report by Service, ...

Particle Works is making major contributions to the field of nanomedicine by producing game-changing automated microfluidic systems with the potential to improve efficiency in the nanotherapeutic drug ...

Hyderabad, India, July 1, 2015: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage ...

Ensuring protein drugs are stable is a complex challenge. To be successful, formulation developers need to think beyond the molecule and also consider how the finished product will be handled after it ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...

The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...